An accomplished pharmaceutical executive with a broad range of management and sales experience, specialising in the Oncology Therapeutic area. The last 12 years have been dedicated to developing access to precision medicine by improving awareness and affordability to genetic testing. Kirsty was the first in Australia to develop this role and most recently was responsible for the global diagnostic strategy development of multiple cancer types in AstraZeneca's portfolio for the leading 8 markets.
Kirsty is an entrepreneurial thinking and results oriented individual, who thrives on a challenge. Her career success has largely been based on developing key partnerships with internal and external colleagues to unlock financial restraints, achieve commercial success and ultimately improve outcomes for patients, which is her true motivator.